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Abstract
Objective: To study alcohol consumption in relation to ovarian cancer risk in a prospective cohort study.
Methods: The Netherlands Cohort Study on diet and cancer was initiated in 1986. A self-administered questionnaire
on dietary habits and other risk factors for cancer was completed by 62,573 postmenopausal women. Follow-up for
cancer was established by annual record linkages with the Netherlands Cancer Registry. After 9.3 years of follow-
up, 214 incident invasive epithelial ovarian cancer cases and 2211 subcohort members with complete data on alcohol
intake were available for analysis. All incidence rate ratios (RRs) were corrected for age, use of oral contraceptives,
parity, height, body mass index, energy intake and current cigarette smoking.
Results: The RRs of ovarian cancer for women who consumed up to 5, 15 and >15 g of alcohol per day were 1.13
(95% conﬁdence interval, 95% CI¼ 0.79–1.63), 0.85 (95% CI¼ 0.53–1.37) and 0.92 (95% CI¼ 0.55–1.54),
respectively, compared to non-drinkers. Alcohol consumption in the form of wine, beer or liquor was not associated
with ovarian cancer risk.
Conclusion: These data do not suggest a major association between alcohol intake and ovarian cancer risk in this
population.
Introduction
In 1988, the International Agency for Research on
Cancer concluded that there is suﬃcient evidence for the
carcinogenicity of alcohol in humans [1]. Although
experimental studies have not shown a carcinogenic
eﬀect of ethanol as such, the epidemiological data with
respect to several cancers are strong [1, 2].
The eﬀect of alcohol on the risk of ovarian cancer may,
however, be diﬀerent. Alcohol may have an enhancing
eﬀect, as it has in other sites, but it could also have a
protective eﬀect [3]. In premenopausal women, alcohol
intake has been associated with reduced serum levels of
gonadotropins [4]. Also, alcohol-fed rats developed
signiﬁcant ovarian atrophy, showing an absence of
corpora lutea and developing follicles [5]. Based on these
observations, two of the hypotheses for the etiology of
ovarian cancer – the ‘incessant ovulation’ theory of
Fathalla [6] and the ‘excessive gonadotropin’ hypothesis
of Cramer and Welch [7] – predict a protective eﬀect of
alcohol intake on the risk of ovarian cancer.
The results of published epidemiological studies
investigating the association between alcohol consump-
tion and ovarian cancer have been heterogeneous,
however. Most case–control studies, often hospital-
based, did not ﬁnd a statistically signiﬁcant association
[8–16]. Two case–control studies reported statistically
signiﬁcantly decreased risks [17, 18], whereas two other
case–control studies reported increased risks [19, 20]. To
date, only two cohort studies have been conducted. A
cohort study with 76 cases among alcoholic women in
Sweden [21] showed that the incidence of ovarian cancer
was decreased among women under 60 years relative to
the general population. Among women of 60 years and
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older, however, there was no association. The second
cohort study, with 139 cases, was conducted in Iowa,
and found a signiﬁcantly decreased risk of ovarian
cancer [22]. Of the prospective cohort studies, only one
adjusted for confounders. We therefore decided to study
alcohol consumption in relation to ovarian cancer in a
prospective cohort study, allowing adjustment for the
main potential confounders.
Materials and methods
The cohort
The Netherlands Cohort Study on diet and cancer
(NLCS) started in September 1986, when 62,573 Dutch
women aged 55–69 years were enrolled in the cohort
[23]. All women were presumed to be postmenopausal.
Data processing and analysis were based on the case–
cohort approach, in which the cases were enumerated
for the entire cohort (numerator information on inci-
dence rates), while the accumulated person-years of the
entire cohort were estimated using a subcohort sample
(providing the denominator information). Following
this approach, a subcohort of 2589 women was sampled
randomly from the cohort after the baseline exposure
measurement. The design of the study has been
described in detail before [23]. One hundred and forty-
ﬁve prevalent cancer cases (other than skin cancer) were
excluded from the subcohort. In addition, women in the
subcohort who had reported at baseline to have under-
gone an oophorectomy (n¼ 32) were excluded, leaving
2412 subcohort members.
Follow-up
The subcohort has been followed up biennially by mail
for vital status information. The vital status of subco-
hort members who did not respond to the letter was
completed by contacting the municipal register. Incident
cancer cases occurring in the entire cohort were identi-
ﬁed by record linkage to the Netherlands Cancer
Registry and the Netherlands National Database for
Pathology (PALGA) [23, 24].
The present analysis is restricted to cancer incidence in
the 9.3-year follow-up period from September 1986 to
December 1995. The completeness of cancer follow-up
was estimated to be at least 96% [25], and no subcohort
members were lost to follow-up. During a follow-up
period of 9.3 years, 256 incident, microscopically con-
ﬁrmed, primary ovarian malignancies were detected.
After exclusion of non-epithelial tumors (n¼ 15) and
borderline invasive tumors (n¼ 6), 235 cases with
epithelial ovarian cancer remained available.
Questionnaire data
At baseline, cohort members completed a self-adminis-
tered questionnaire on risk factors for cancer. The
food-frequency section concentrated on habitual con-
sumption during the preceding year. Consumption of
alcoholic beverages was addressed by questions on beer,
red wine, white wine, sherry, other fortiﬁed wines,
liqueur, and liquor. The questionnaire data of all cases
and subcohort members were key-entered twice and
processed in a manner blinded with respect to case/
subcohort status in order to minimize observer bias in
the coding and interpretation of data. The questionnaire
has been validated against a nine-day diet record [26, 27].
The Pearson correlation coeﬃcient between the mean
daily ethanol intake assessed by the questionnaire and
that estimated by the 9-day record was 0.86 for all
subjects and 0.78 for users of alcoholic beverages [26].
Respondents who drank alcoholic beverages less than
once a month were considered non-drinkers. Four items
from the questionnaire (i.e., red wine, white wine, sherry,
and liqueur) were combined into one wine variable, since
these items were substantially correlated and separate
treatment would have resulted in a sparsity of data.
Mean daily alcohol consumption was calculated using
the Dutch food composition table [28]. On the basis of
pilot study data, standard glass sizes were deﬁned as
200 ml for beer, 105 ml for wine, 80 ml for sherry, and
45 ml for both liqueur and liquor, corresponding to 8,
10, 11, 7, and 13 g of alcohol, respectively.
Data analysis
The analysis was based on 214 cases and 2211 subcohort
members for whom data on alcohol consumption were
complete. Of the 214 epithelial ovarian carcinomas,
35.5% were serous carcinomas, 10.7% endometrioid
carcinomas, 10.7% mucinous carcinomas, 4.7% clear
cell carcinomas, 35.5% adenocarcinomas not otherwise
speciﬁed and 2.8% other carcinomas.
The following variables were considered as potential
confounders [3, 29, 30]: age (years); use of oral contra-
ceptives (ever versus never); parity (number of children);
use of postmenopausal hormones (ever versus never);
height (cm); body mass index (kg/m2); family history of
breast and/or ovarian cancer (yes versus no); hysterec-
tomy (yes versus no); total energy intake (including
energy intake from alcoholic drinks; kcal/day); and
current cigarette smoking (yes versus no). Family history
was considered positive if breast and/or ovarian cancer
was reported in at least one ﬁrst-degree relative, i.e.,
mother, sister or daughter. A variable was considered a
confounder if (1) the variable was statistically signiﬁ-
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cantly associated with alcohol consumption; (2) the
variable is known to be a risk factor for ovarian cancer
in this population and (3) the association of alcohol
consumption with the risk of ovarian cancer changed
by more than 10% after adjustment for the variable.
Cases and subcohort members were excluded from
multivariate analyses if information on confounders was
missing.
Incidence rate ratios (RR) and corresponding 95%
conﬁdence intervals (CI) for ovarian cancer were esti-
mated in the age-adjusted and multivariate case–cohort
analyses with categorized and continuous alcohol vari-
ables, using the Cox proportional hazards model [31]
processed with the Stata statistical software package
[32]. Standard errors were estimated using the robust
Hubert–White sandwich estimator to account for addi-
tional variance introduced by sampling from the cohort.
This method is equivalent to the variance–covariance
estimator presented by Barlow [33]. The proportional
hazards assumption was tested using the scaled Schoen-
feld residuals [34]. Tests for dose–response trends in risk
of ovarian cancer were assessed by ﬁtting ordinal
exposure variables as continuous terms. Two-sided
p-values are reported throughout the paper.
Results
Among subcohort members, women who drank alcohol
were slightly younger, had fewer children on average,
were taller and leaner and had a higher energy intake
than non-drinkers (see Table 1). Of the women who
drank alcohol, more had ever used oral contraceptives
or postmenopausal hormonal therapy, and more were
current cigarette smokers. Because age, use of oral
contraceptives, parity, height, body mass index, energy
intake and current smoking changed the risk estimates
for the association of alcohol consumption with the risk
of ovarian cancer, these variables were included as
confounders in the multivariate analyses. After exclu-
sion of cases and subcohort members with incomplete
information on confounders, 180 cases and 2005 sub-
cohort members were available for multivariate analysis.
The consumption patterns among the women were
quite stable. Only 4.7% of the cohort members and
2.8% of the cases who consumed less than one alcoholic
drink per month at baseline reported to have used
alcoholic drinks ﬁve years before baseline.
Women who drank 15 g of alcohol or more per day
had a multivariate adjusted relative risk (RR) of 0.92
(95% CI¼ 0.55–1.54) compared to women who did not
drink alcohol (Table 2). The RRs for women who
consumed up to 5 or 15 g per day were not signiﬁcantly
diﬀerent from 1 either. The p-value for trend (p-trend)
was non-signiﬁcant. The multivariate RR for 15 g or
more of alcohol from wine was 1.00 (95% CI¼ 0.57–
1.75; p trend¼ 0.95) compared to women who did not
drink wine. The multivariate RR for drinking beer was
0.91 (95% CI¼ 0.52–1.58) and the RR for drinking
liquor was 0.76 (95% CI¼ 0.46–1.27) compared to non-
drinkers of beer and liquor, respectively. In order to
evaluate possible bias because of the presence of
Table 1. Means (standard deviation) and distribution of potential confounders in the subcohort according to alcohol consumption, the
Netherlands Cohort Study, 1986–1995
Characteristic Alcohol consumption
No
(n = 726)
0.1–4 g/day
(n = 791)
5–14 g/day
(n = 408)
‡15 g/day
(n = 286)
Mean (SDa) Mean (SDa) Mean (SDa) Mean (SDa)
Age at baseline Years 61.7 (4.3) 61.4 (4.3) 61.5 (4.2) 60.8 (4.2)
Parity no. of children 3.0 (2.4) 2.8 (2.3) 2.7 (2.0) 2.6 (2.0)
Height cm 164.8 (6.7) 165.3 (6.1) 165.2 (5.9) 166.0 (5.8)
Body mass index kg/m2 25.5 (3.9) 25.2 (3.4) 24.5 (3.2) 24.4 (3.2)
Energy intake kcal 1617 (425) 1674 (382) 1724 (387) 1793 (411)
% % % %
Use of oral contraceptives Yes 21.0 22.9 30.3 33.7
Use of postmenopausal hormonal therapy Yes 10.8 11.8 14.8 15.4
Hysterectomy Yes 5.4 5.2 9.6 8.0
Family history of breast/ovarian cancerb Yes 9.6 9.5 7.1 8.0
Currently smoking cigarettes Yes 18.9 16.6 26.0 38.1
a SD, standard deviation.
b Family history was considered positive if breast and/or ovarian cancer was reported in at least one ﬁrst-degree relative, i.e. mother, sister or
daughter.
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subclinical disease at baseline, the data were analyzed
excluding cases and subcohort members with less than
one year of follow-up. These risk estimates were not
substantially diﬀerent (data not shown).
We also examined eﬀect modiﬁcation of the associa-
tion between alcohol consumption and ovarian cancer
by age at baseline, use of oral contraceptives, parity and
body mass at baseline (Table 3). There was no interac-
tion between age at baseline and alcohol consumption
on the one hand and ovarian cancer risk on the other.
Among women who had never used oral contraceptives,
there was no association with alcohol consumption
(RR¼ 0.99; 95% CI¼ 0.69–1.42), while the risk among
ever users of oral contraceptives was only slightly and
non-signiﬁcantly increased (RR¼ 1.22; 95% CI¼ 0.51–
2.91). The interaction between alcohol consumption and
the number of children in terms of the risk of ovarian
cancer was not consistent. The interaction with body
mass index, however, appeared to show a trend.
In women of normal weight (BMI < 25 kg/m2) alcohol
consumption was associated with a non-signiﬁ-
cantly increased relative risk of 1.33 (95% CI¼ 0.82–
2.14). In overweight (BMI 25–<30 kg/m2) and obese
(BMI ‡ 30 kg/m2) women, alcohol consumption was
associated with non-signiﬁcantly decreased relative risks
of 0.95 (95% CI¼ 0.54–1.67) and 0.52 (95% CI¼ 0.20–
1.34), respectively. The p-value for interaction was 0.21.
There was no interaction between energy intake and
alcohol consumption on the one hand and ovarian
cancer risk on the other.
Discussion
This cohort study, with a large number of cases, did not
demonstrate a major association between alcohol intake
Table 3. RRs and 95% CI for ovarian cancer in women who consume alcohol compared to those NOT drinking alcohol among subgroups
deﬁned by various risk factors in the Netherlands Cohort Study, 1986–1995
Subgroup Cases
no
Subcohort
person years
Drinkersa
RRb,c 95% CI
All 180 17,928 1.03 0.74–1.43
Age at baseline (years)
55–59 62 7138 1.22 0.68–2.17
60–64 56 5901 0.73 0.42–1.29
65–69 62 4889 1.19 0.67–2.11
p interaction: 0.38
Use of oral contraceptives
Never 150 13,287 0.99 0.69–1.42
Ever 30 4640 1.22 0.51–2.91
Parity (number of children)
No 50 3115 1.01 0.52–1.96
1 14 1527 0.50 0.16–1.49
2 38 3980 1.98 0.89–4.41
3+ 78 9307 0.90 0.56–1.46
p interaction: 0.22
Body mass at baseline (kg/m2)
Normal (<25) 98 10,098 1.33 0.82–2.14
Overweight (25–<30) 61 6286 0.95 0.54–1.67
Obese (30+) 21 1544 0.52 0.20–1.34
p interaction: 0.21
Energy intake (kcal/day)
<1745 35 3527 1.07 0.53–2.17
1745–<1998 38 3562 1.86 0.83–4.19
1998–<2250 31 3563 0.51 0.24–1.05
2250–<2563 41 3547 0.94 0.46–1.92
‡2563 35 3729 1.02 0.46–2.25
p interaction: 0.23
a Compared to non-drinkers (=reference category).
b RR = rate ratio; 95% CI = 95% Conﬁdence Interval.
c Adjusted for age (years), use of oral contraceptives (ever versus never), parity (number of children), height (cm), body mass index (kg/m2),
total energy intake (kcal), and current cigarette smoking (yes versus no).
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and ovarian cancer incidence after controlling for
several potential confounders among postmenopausal
women. RRs for women who drank alcohol were
slightly decreased compared to those for non-drinkers,
but the diﬀerence was not statistically signiﬁcant.
An important strength of our study is the prospective
design, which makes recall bias unlikely. Bias resulting
from the presence of subclinical disease at baseline is
also unlikely, because an analysis excluding all cases and
subcohort members with less than one year of follow-up
did not change the results signiﬁcantly. RRs were not
signiﬁcantly diﬀerent. Selection bias is unlikely, given
the high degree of completeness of the follow-up in
terms of cases and subcohort person years [25, 35].
Another advantage is that the assessment of alcohol
consumption in the NLCS allowed us to evaluate a
possible association between diﬀerent types of alcoholic
beverage and ovarian cancer risk.
A possible limitation of our study is misclassiﬁcation
of alcohol consumption. The correlation between the
alcohol consumption measured by the questionnaire and
the measurement in a nine-day record was high, due to
the large variation in alcohol consumption [26]. Also, if
misclassiﬁcation has occurred, this is expected to be
non-diﬀerential and risk estimates are most likely biased
toward no eﬀect. Abstainers and ex-drinkers were not
separated in our study, but were included in our
reference category of non-drinkers. Since ex-drinkers
may diﬀer from abstainers in ovarian cancer risk, our
estimated risks might be biased in either direction. The
proportion of ex-drinkers is probably small, as only
4.7% of the cohort members and 2.8% of the cases who
consumed less than one alcoholic drink per month
reported to have drunk alcohol ﬁve years before base-
line. We were able to control for confounding by the
most important risk factors of ovarian cancer [29].
Of the hospital-based case–control studies that have
investigated the association between alcohol and the risk
of ovarian cancer (for an overview of all epidemiological
studies see Table 4), two studies did not ﬁnd an eﬀect [8,
9] and ﬁve studies reported an increased risk [10–12, 19,
20]. Two of these studies observed a statistically
signiﬁcant trend with increasing alcohol consumption
[19, 20]. One other study [18] found a protective eﬀect of
alcohol consumption, which became statistically non-
signiﬁcant in multivariate analysis. One other study did
not ﬁnd an overall eﬀect [13], but found a protective
eﬀect of alcohol consumption in women under 50 years
of age, though the eﬀect was not statistically signiﬁcant.
It must be remembered, however, that hospital-based
case–control studies on alcohol consumption may suﬀer
from selection and information bias, because alcohol is
linked to many diseases that require hospitalization.
Three population-based case–control studies have
published results on alcohol and ovarian cancer [14,
15, 17], of which two found non-signiﬁcant protective
eﬀects of alcohol consumption [14, 17] and the third a
non-signiﬁcantly increased risk [15]. Two cohort studies
have studied the issue. In Sweden [21], the incidence of
ovarian cancer at the age of 60 years and older was
unaltered in alcoholic women, but the incidence under
the age of 60 was 24% lower than expected in alcoholic
women compared to the general population. The study
design did not allow adjustment for confounding. In the
Iowa Women’s Health Study, a decreasing risk of
ovarian cancer was observed with increasing alcohol
consumption [22]. In the highest category, the RR was
0.49 after adjustment for several confounders.
Diﬀerences in the level of alcohol consumption do not
explain the heterogeneity of the outcomes. The Iowa
Women’s Health Study [22] observed a statistically
signiﬁcantly decreased risk of ovarian cancer, but alcohol
consumption even in the highest category was rather low
(about one glass/day). The Swedish cohort study [21] was
conducted among alcoholics, with a high consumption of
alcohol. These women, however, probably diﬀered in
many respects from the general population, making it
diﬃcult to interpret these results. Some of the studies that
observed an increased risk, although not always statis-
tically signiﬁcant, involved persons with a relatively high
consumption of alcohol: more than two [11, 12] or more
than three glasses per day [15, 20]. The alcohol consump-
tion in the current study was relatively low: the highest
category consisted of women who drank an average of
1.5 or more glasses of alcoholic beverage per day.
It is conceivable that both carcinogenic and protec-
tive eﬀects of alcohol play a role in ovarian cancer.
Carcinogenic eﬀects may include an altered carcinogen
metabolism [2] or alcohol-related nutritional deﬁcien-
cies, e.g., a lack of folate [36]. The main etiological
hypotheses of ovarian cancer, i.e., the ‘incessant ovula-
tion’ theory of Fathalla [6] and the ‘excessive gonado-
tropins’ hypothesis of Cramer and Welch [7], indicate
that suppression of ovulation and leveling of the peaks
in gonadotropin levels may protect against ovarian
cancer. This potential protective eﬀect of alcohol is
probably largest in the fertile period, which is in
agreement with studies showing decreased risk ratios
especially in younger women [13, 17, 21], but not with
other studies showing increased risks in younger women
[9, 20]. The current study showed a slightly increased
risk in the youngest age group. It must be remembered,
however, that the women were already 55–69 years
of age at baseline, and the power to detect a protective
eﬀect – if any – in the youngest women of our
cohort was probably too small. Based on Fathalla’s
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Table 4. Summary of epidemiological study ﬁndings on the relation between alcohol intake and ovarian cancer risk
Reference Study population Age (years) Level of alcohol consumption RR/OR (95% CI)a p trend
Hospital-based case–control studies
Williams & Horm [10] 153 cases All Non-drinkers 1 (reference) –
3035 controls 1–50 oz-years 0.74 (NS)
51 or more oz-years 0.85 (NS)
Byers et al. [13] 274 cases 30–79 Non-drinkers 1 (reference) NS
1034 controls 1–8 drinks/week 0.92 (NS)
9 drinks/week 0.83 (NS)
Tzonou et al. [19] 150 cases All Non-drinkers 1 (reference)
250 controls Drinkers 1.5 (0.9–2.5)
Years of consumption:
1–9 0.7 (0.2–2.2) 0.02
10–19 1.9 (0.7–4.8)
20–29 2.9 (1.1–7.6)
30+ 1.7 (0.8–3.5)
Mori et al. [8] 110 cases All <once/week 1 (reference) –
220 controls ‡once/week 1.0 (0.6–1.9)
Hartge et al. [11] 296 cases 20–79 Non-drinkers 1 (reference) 0.14
343 controls Occasional 1.1 (0.7–1.9)
1–6 drinks/week 1.4 (0.8–2.3)
7–13 drinks/week 1.2 (0.7–2.2)
‡14 drinks/week 1.5 (0.8–2.8)
Kato et al. [18] 417 cases 20+ None 1 (reference) –
8920 controls Occasional 1.10 (0.79–1.53)
Daily 0.38 (0.16–0.90)
La Vecchia et al. [20] 801 cases <75 None 1 (reference) 0.04
2114 controls <1 drink/day 1.0 (0.7–1.4)
1–<2 drinks/day 1.1 (0.9–1.4)
2–<3 drinks/day 1.2 (1.0–1.5)
‡3 drinks/day 1.3 (0.9–1.8)
Polychronopoulou et al. [12] 189 cases <75 None 1 (reference) –
200 controls £1 glass/day 0.85 (0.52–1.39)
1–£2 glasses/day 0.94 (0.49–1.79)
>2 glasses/day 1.62 (0.66–3.96)
Nandakumar et al. [16] 97 cases 48.3c History of alcohol consumption: –
194 controls No 1 (reference)
Yes 1.3 (0.2–8.0)
Tavani et al. [9] 1031 cases <80 Never drinkers 1 (reference) 0.41
2411 controls <12 g/day 1.02 (0.80–1.30)
>12–24 g/day 1.29 (1.00–1.67)
>24–36 g/day 1.04 (0.80–1.36)
‡36 g/day 1.09 (0.76–1.57)
Population-based case–control studies
Gwinn et al. [17] 433 cases 20–54 None 1 (reference) –
2915 controls <50 g/week 1.0 (0.7–1.4)
50–149 g/week 0.8 (0.5–1.1)
150–249 g/week 1.0 (0.6–1.6)
‡250 g/week 0.5 (0.2–0.9)
Whittemore et al. [14] 188 cases 18–74 None 1 (reference) –
539 controls ‡20 drinks/week 0.66 (p = 0.34)
Kuper et al. [15] 549 cases None 1 (reference) 0.20
516 controls 0–1 drinks/day 0.91 (0.67–1.23)
>1–2 drinks/day 1.33 (0.88–2.01)
>2–3 drinks/day 0.92 (0.50–1.69)
>3 drinks/day 1.35 (0.80–2.26)
Cohort studies
Kushi et al. [22] 29,083 subjects 55–69b None 1 (reference) 0.01
139 cases 0.9–3.9 g/day 1.37 (0.39–2.04)
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theory, one might also expect that, because of the
similarity of the proposed mechanisms of protection,
alcohol would not provide additional protection against
ovarian cancer in women who used oral contraceptives,
as ovulation is already suppressed in these women. In
the current study, women who used oral contracep-
tives and consumed alcohol had a slightly but not
statistically signiﬁcantly increased risk of ovarian can-
cer compared to women who did not consume alcohol.
Two other case–control studies have studied the
interaction between the use of oral contraceptives
and alcohol intake. Both studies observed a non-
signiﬁcant protective eﬀect of alcohol intake in
women who had ever used oral contraceptives [9, 20].
An interesting ﬁnding in the current study was
the decreased – although not statistically signiﬁcantly
decreased – risk of ovarian cancer in overweight and
obese women who consumed alcohol. This was not
conﬁrmed in the only case–control study that investi-
gated this interaction [9]. In view of the possibility of a
chance ﬁnding, conﬁrmation of this result in other
studies is needed. Tavani [9] observed a protective eﬀect
of alcohol intake among women with a low energy
intake. This was not conﬁrmed in the current study.
In conclusion, alcohol intake was not associated
with ovarian cancer risk in our cohort study. We cannot
exclude that alcohol intake protects against ovarian
cancer occurring at younger age, because the women
in our cohort were already too old at baseline to
demonstrate or refute this eﬀect. Future studies on
alcohol intake should focus on younger cohorts
and should investigate a possible interaction with
oral contraceptives and body mass index.
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